Skip to content
Study details
Enrolling now

Omental Tissue Autograft in Human Recurrent Glioblastoma Multiforme (rGBM)

Northwell Health
NCT IDNCT05979064ClinicalTrials.gov data as of Apr 2026
Target enrollment

10

Study length

about 4.1 years

Ages

18+

Locations

1 site in NY

What this study is about

Researchers are testing the safety of a procedure called omental tissue autograft, where omentum (fatty tissue from your abdomen) is harvested and implanted into the brain cavity of people with recurrent glioblastoma multiforme (rGBM). The trial will last for approximately 1487 days.

Simplified from trial records by PatientMatch.

What you may be asked to do

  • 1.Undergo Laparoscopically harvested omental tissue autograft

Participation Burden

What's physically and logistically required of participants.

Logistics & Travel
In-person visits

Requires travel to a study site

Physical Intervention
Standard

How treatment is administered

Treatment Assignment
All receive treatment

Everyone gets the investigational treatment.

Extracted study details

Pulled from the trial record to show what is being tested and what the study is measuring.

Endpoints

Primary: Safety parameter: proportion of patients experiencing rapidly progressive disease as indicated by MRI using RANO Criteria harvested omental graft for recurrent glioblastoma multiforme (rGBM).

Secondary: Overall Survival (OS), Progression Free Survival (PFS)

Body systems

Neurology, Oncology